A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer
Mayo Clinic
Mayo Clinic
Turning Point Therapeutics, Inc.
Inhibrx Biosciences, Inc
Tanabe Pharma America, Inc.
Hookipa Biotech GmbH
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Numab Therapeutics AG
Intensity Therapeutics, Inc.
Vaccinex Inc.
Simcha IL-18, Inc.
Atara Biotherapeutics
Cancer Research UK
Evopoint Biosciences Inc.
Icahn School of Medicine at Mount Sinai
Kineta Inc.
The University of Texas Health Science Center at San Antonio
Genocea Biosciences, Inc.
Dana-Farber Cancer Institute
University of Pittsburgh
M.D. Anderson Cancer Center